These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1588579)

  • 1. Proteolytic activity of Clostridium difficile.
    Seddon SV; Borriello SP
    J Med Microbiol; 1992 May; 36(5):307-11. PubMed ID: 1588579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model.
    Seddon SV; Hemingway I; Borriello SP
    J Med Microbiol; 1990 Mar; 31(3):169-74. PubMed ID: 2156075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease activity of Clostridium difficile strains.
    Poilane I; Karjalainen T; Barc MC; Bourlioux P; Collignon A
    Can J Microbiol; 1998 Feb; 44(2):157-61. PubMed ID: 9543717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
    Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
    J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of an extracellular protease from Clostridium difficile].
    Janoir C; Grénery J; Savariau-Lacomme MP; Collignon A
    Pathol Biol (Paris); 2004 Oct; 52(8):444-9. PubMed ID: 15465262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.
    Goldenberg SD; French GL
    J Infect; 2011 May; 62(5):355-62. PubMed ID: 21396957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of toxin A and toxin B in the virulence of Clostridium difficile.
    Carter GP; Rood JI; Lyras D
    Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
    René P; Frenette CP; Schiller I; Dendukuri N; Brassard P; Fenn S; Loo VG
    Diagn Microbiol Infect Dis; 2012 May; 73(1):94-6. PubMed ID: 22424900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of thermoresistance spores of Clostridium difficile strains belonging to different toxigenicity groups].
    Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2004; 56(2):155-9. PubMed ID: 15544087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation of DNA sequences from the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile into a non-toxigenic strain.
    Ackermann G; Tang YJ; Henderson JP; Rodloff AC; Silva J; Cohen SH
    Mol Cell Probes; 2001 Oct; 15(5):301-6. PubMed ID: 11735302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of ribose-5-phosphate isomerases from Clostridium difficile and Thermotoga maritima.
    Yeom SJ; Kim BN; Park CS; Oh DK
    Biotechnol Lett; 2010 Jun; 32(6):829-35. PubMed ID: 20155483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of hamsters with epidemiologically important strains of Clostridium difficile.
    Sambol SP; Tang JK; Merrigan MM; Johnson S; Gerding DN
    J Infect Dis; 2001 Jun; 183(12):1760-6. PubMed ID: 11372028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins.
    Janoir C; Péchiné S; Grosdidier C; Collignon A
    J Bacteriol; 2007 Oct; 189(20):7174-80. PubMed ID: 17693508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of environmental conditions on the expression and the maturation process of the Clostridium difficile surface associated protease Cwp84.
    Chapetón Montes D; Collignon A; Janoir C
    Anaerobe; 2013 Feb; 19():79-82. PubMed ID: 23257307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells.
    Kramer MD; Binninger L; Schirrmacher V; Moll H; Prester M; Nerz G; Simon MM
    J Immunol; 1986 Jun; 136(12):4644-51. PubMed ID: 2423597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile in goats and sheep in Slovenia: characterisation of strains and evidence of age-related shedding.
    Avberšek J; Pirš T; Pate M; Rupnik M; Ocepek M
    Anaerobe; 2014 Aug; 28():163-7. PubMed ID: 24960532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen.
    Péchiné S; Denève C; Le Monnier A; Hoys S; Janoir C; Collignon A
    FEMS Immunol Med Microbiol; 2011 Oct; 63(1):73-81. PubMed ID: 21707776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
    Razaq N; Sambol S; Nagaro K; Zukowski W; Cheknis A; Johnson S; Gerding DN
    J Infect Dis; 2007 Dec; 196(12):1813-9. PubMed ID: 18190262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12th C. L. Oakley lecture. Pathogenesis of Clostridium difficile infection of the gut.
    Borriello SP
    J Med Microbiol; 1990 Dec; 33(4):207-15. PubMed ID: 2258909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.